Cancer Research
RESEARCH UPDATE — MAY 2021
The Farrah Fawcett Foundation is pleased to announce a new research team partnership with Stand Up To Cancer.
The Stand Up To Cancer – Fanconi Anemia Research Fund – Farrah Fawcett Foundation Head and Neck Cancer Research Team, with support from American Head and Neck Society and Head and Neck Cancer Alliance, will bring new approaches for target identification and translational research. These innovations could lead to better treatment options for patients with head and neck squamous cell carcinoma (HNSCC) cancer.
About the Head & Neck Cancer Research Team
The research group will focus on HPV-related and Fanconi Anemia (FA)-related cancers. Investigators across several disciplines, including oncology, biology, engineering, chemistry, physics, and other areas, will collaborate, each bringing their expertise to bear against HNSCC, its connection with HPV, and its association with defects in the FA pathway.
The research group will focus on HPV-related and Fanconi Anemia (FA)-related cancers. Investigators across several disciplines, including oncology, biology, engineering, chemistry, physics, and other areas, will collaborate, each bringing their expertise to bear against HNSCC, its connection with HPV, and its association with defects in the FA pathway.
The Research Team is supported by the Fanconi Anemia Research Fund, the Farrah Fawcett Foundation, the American Head & Neck Society, and Head and Neck Cancer Alliance.
The Farrah Fawcett Foundation and Stand Up To Cancer have collaborated by creating a research team dedicated to HPV-related cancers. To date, the FFF has donated over $1,500,000 with participation from the HPV and Anal Cancer Foundation. The team is now at clinical trial at Dana Farber Cancer Institute in Boston. According to the CDC, high-risk human papilloma viruses are responsible for 90% of anal cancers (the cancer that took Farrah’s life) and cervical cancers, as well as many vaginal, vulvar, penile, and oropharyngeal cancers.
The Farrah Fawcett Foundation is committed to helping find a cure. A large part of our focus is to support the most effective and cutting-edge research possible. We are specifically interested in HPV-related cancers.
granting partners
